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Journal of Experimental & Clinical Cancer Research (JECCR),
the official journal of the "Regina Elena" National Cancer
Institute [1] of Rome, has moved to BioMed Central's
open access publishing platform. Overseen by the Editor-
in-Chief Mauro Castelli and supported by an interna-
tional Editorial Board [2], the journal aims to provide a
high-quality forum for basic and translational work in
oncology.
First launched in 1982, JECCR joined BioMed Central in
order to provide rapid dissemination of scientific results
to the widest possible global audience. Furthermore,
authors submitting to JECCR can expect a fast turnaround
time, benefitting from an efficient review process and
publication immediately upon acceptance. JECCR's con-
tent will be widely indexed (for instance by PubMed,
Medline, Thomson/ISI, Embase, and CAS) and covered by
a range of freely accessible full-text archives [3].
JECCR publishes scientific studies on the biological, epi-
demiological, immunological, pathological, radiobiologi-
cal, and clinical aspects of oncology. Topics considered
range from molecular genetics via infectious agents to sur-
gery and therapeutic approaches and outcomes. The
broad oncological focus, combined with the Editors' expe-
rience in evaluating and conducting systematic reviews
and developing clinical practice guidelines, makes JECCR
an attractive forum for publishing reviews and guidelines.
This focus, well documented in an Editorial by H. J.
Schünemann [4], goes very well together with the
approach now being widely applied by many interna-
tional and national organizations, including the World
Health Organization (WHO), Cochrane Collaboration,
American College of Physicians (ACP), and the National
Institutes for Health and Clinical Excellence in the U.K.
(NICE).
In response to increasing requests JECCR has decided to
devote particular attention to more specific areas of cancer
investigation. To this end, specific sections and subsec-
tions under the supervision of expert Editors have been
created: the new topics include Gastrointestinal Stromal
Tumors (GIST), Lung and Pleural Tumors, and Preclinical
Investigations in spontaneous animal models.
We believe that the new editorial changes combined with
the advantages of BioMed Central's open access publish-
ing platform will greatly improve JECCR's dissemination
and visibility. The journal's online archive back to 1999
remains available from its old homepage. [5]
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